# EDGAR Filing Document

**Accession Number:** 0001641631
**File Stem:** 0001493152-26-004741
**Filing Date:** 2026-2
**Character Count:** 7875
**Document Hash:** 622641ef454d4daa4031b42dc871e5ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-004741.hdr.sgml**: 20260202

**ACCESSION NUMBER**: 0001493152-26-004741

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260130

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260202

**DATE AS OF CHANGE**: 20260202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Beyond Air, Inc.
- **CENTRAL INDEX KEY:** 0001641631
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 473812456
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38892
- **FILM NUMBER:** 26587838

**BUSINESS ADDRESS:**
- **STREET 1:** 900 STEWART AVENUE
- **STREET 2:** SUITE 301
- **CITY:** GARDEN CITY
- **STATE:** NY
- **ZIP:** 11530
- **BUSINESS PHONE:** 516-665-8200

**MAIL ADDRESS:**
- **STREET 1:** 900 STEWART AVENUE
- **STREET 2:** SUITE 301
- **CITY:** GARDEN CITY
- **STATE:** NY
- **ZIP:** 11530

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AIT Therapeutics, Inc.
- **DATE OF NAME CHANGE:** 20170117

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KokiCare, Inc.
- **DATE OF NAME CHANGE:** 20150507

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the**

**Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): January 30, 2026**

**Beyond Air, Inc.**

**(Exact Name of Registrant as Specified in Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-38892** | **47-3812456** |
| **(State or Other Jurisdiction**<br> **of Incorporation)** | **(Commission**<br> **File Number)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**900 Stewart Avenue, Suite 301**

**Garden City, NY 11530**

**(Address of Principal Executive Offices and Zip Code)**

**(516) 665-8200**

**Registrant's Telephone Number, Including Area Code**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| **Common Stock, par value $.0001 per share** | **XAIR** | **The Nasdaq Stock Market LLC** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 5.07 Submission of Matters to a Vote of Security Holders**

On January 30, 2026, Beyond Air, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting"). As of December 3, 2025, the date of record for determining the stockholders entitled to vote on the proposals presented at the Annual Meeting, there were 8,009,488 shares of common stock issued and outstanding and entitled to vote at the Annual Meeting. A total of 4,221,408 shares of common stock representing in aggregate 52.70% of the shares outstanding and eligible to vote and constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. The final results for each of the matters submitted to a vote of the Company's stockholders at the Annual Meeting are as follows:

*Proposal 1.* At the Annual Meeting, the terms of the members of the Board expired. Six (6) nominees for director were elected to serve until the next annual meeting of stockholders or until their successors are elected and qualified, or until such director's prior death, resignation or removal. The result of the votes to elect the six (6) directors was as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Directors** | **For** | **Withheld** | **Broker Non-Votes** |
| Steven A. Lisi | 1876721 | 140584 | 2204103 |
| Robert S. Goodman | 1900828 | 116477 | 2204103 |
| Robert F. Carey | 1889919 | 127386 | 2204103 |
| Dr. William Forbes | 1302760 | 714545 | 2204103 |
| Yoori Lee | 1259067 | 758238 | 2204103 |
| Erick J. Lucera | 1294661 | 722644 | 2204103 |

---

*Proposal 2.* At the Annual Meeting, the stockholders ratified the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026. The result of the votes to ratify the appointment of WithumSmith+Brown, PC was as follows:

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 4086430 | 20603 | 114375 |

---

*Proposal 3.* At the Annual Meeting, the Company's stockholders approved the Eighth Amended and Restated 2013 Equity Incentive Plan to increase the number of shares reserved for issuance by 850,000. The result of the votes to approve the Eighth Amended and Restated 2013 Equity Incentive Plan:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker Non-Votes** |
| 1119142 | 884509 | 13654 | 2204103 |

---

*Proposal 4.* The Company's stockholders approved the adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there were insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals (the "Adjournment Proposal"). However, since there were sufficient votes at the time of the Annual Meeting to approve Proposals 1, 2, and 3, such adjournment will not be necessary. The result of the votes to approve the adjournment was as follows:

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 2757156 | 1431611 | 32641 |

---

**Item 9.01 Financial Statements and Exhibits.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(d) Exhibits.**

---

| | |
|:---|:---|
| **Exhibit**<br> **No.**  | **Description** |
| 10.1 | [Beyond Air, Inc. Eighth Amended and Restated 2013 Equity Incentive Plan (incorporated by reference from Appendix A to the Proxy Statement for Beyond Air, Inc.'s 2026 Annual Meeting of Stockholders, filed with the SEC on December 19, 2025).](https://www.sec.gov/Archives/edgar/data/1641631/000149315225028563/formdef14a.htm#Y-004) |
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL document). |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **BEYOND AIR, Inc.** | **BEYOND AIR, Inc.** |
| Date: February 2, 2026 | By: | */s/ Steven A. Lisi* |
|  | Name: | Steven A. Lisi |
|  | Title: | Chief Executive Officer |

---